Last reviewed · How we verify
Generalized anxiety disorder
Approved treatments
- Cymbalta · Eli Lilly and Company
Potentiates serotonergic and noradrenergic activity in the CNS through unknown exact mechanisms. - Lexapro · Generic (originally Lundbeck/Forest)
Inhibits CNS neuronal reuptake of serotonin (5-HT), potentiating serotonergic activity. - Effexor · Generic (originally Wyeth/Pfizer)
- Effexor · Pfizer
Potentiates serotonin and norepinephrine in CNS through reuptake inhibition. - Celexa · AbbVie
Celexa works by blocking the reabsorption of serotonin in the brain, allowing more of this neurotransmitter to be available for communication between nerve cells. - Buspar
- Effexor · Wyeth is now a wholly owned subsidiary of Pfizer
- Cital · Ain Shams University
- Xanax · National Taiwan University Hospital
- Xanax · Generic (originally Upjohn/Pfizer)
Short-acting, high-potency benzodiazepine that enhances GABA-A receptor activity, providing rapid anxiolytic relief.
Clinical guidelines
- FDA label — 1L
Duloxetine is indicated for the treatment of generalized anxiety disorder in adults and pediatric patients 7 years of age and older. - FDA label — 1L
Escitalopram is indicated for the treatment of generalized anxiety disorder (GAD) in adults.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Generalized anxiety disorder patent landscape — cliff calendar, originator estates, attackable patents
- Generalized anxiety disorder treatment landscape brief
- Generalized anxiety disorder treatment updates RSS
Frequently asked questions about Generalized anxiety disorder
What drugs treat Generalized anxiety disorder?
Tracked treatments include Cymbalta, Lexapro, Effexor, Celexa, Buspar, Cital, Xanax.
What is the treatment for Generalized anxiety disorder?
Standard treatment for Generalized anxiety disorder includes Cymbalta, Lexapro, Effexor, Celexa, Buspar. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Generalized anxiety disorder?
FDA label publishes guidelines for Generalized anxiety disorder. 2 guideline references tracked.
Related
- Treatment landscape: Generalized anxiety disorder patent cliff · Generalized anxiety disorder CI report
- Treatment: Cymbalta · Eli Lilly and Company
- Treatment: Lexapro · Generic (originally Lundbeck/Forest)
- Treatment: Effexor · Generic (originally Wyeth/Pfizer)
- Treatment: Effexor · Pfizer
- Treatment: Celexa · AbbVie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing